Related Experiment Videos
[Neurochemical approach to epilepsy]
1Department of Pediatrics, Shimane Medical University.
No to Hattatsu = Brain and Development
|March 1, 1994
Summary
Neurotransmitter systems, including excitatory amino acids and GABA, play a crucial role in epilepsy. Altered neurotransmitter levels and receptor sensitivity in animal models and children offer insights into epilepsy mechanisms and potential therapies.
Area of Science:
- Neuroscience
- Neurochemistry
- Epileptology
Context:
- Epilepsy is a complex neurological disorder with diverse underlying mechanisms.
- Understanding the neurochemical basis of epilepsy is crucial for developing effective treatments.
- Existing research highlights the involvement of various neurotransmitter systems.
Purpose:
- To investigate the neurochemical mechanisms underlying epilepsy.
- To examine the role of neurotransmitter systems in animal models and human epilepsy.
- To explore the mechanisms of anticonvulsant and proconvulsant agents and potential new therapies.
Summary:
- Studies in El mice revealed increased excitatory amino acid activity and decreased noradrenergic activity correlated with seizure susceptibility.
- Reduced GABA sensitivity was observed in audiogenic seizure-susceptible DBA 2 J mice.
- Tremor rats showed altered benzodiazepine receptor densities and GABA concentrations, potentially linked to absence-like seizures.
- Anticonvulsant ACTH may act by antagonizing glutamate, while thyroid hormone and penicillin exhibit proconvulsant effects via benzodiazepine receptors and GABA-gated chloride influx, respectively.
- Cerebrospinal fluid (CSF) GABA levels were lower in children with infantile spasms, suggesting a role for GABA deficiency.
- Vitamin B6 and valproic acid combination demonstrated efficacy and safety for infantile spasms.
Impact:
- Provides neurochemical insights into epilepsy pathogenesis across different models and patient populations.
- Elucidates the mechanisms of action for certain anticonvulsant and proconvulsant substances.
- Highlights the potential of targeting neurotransmitter systems for novel epilepsy therapies, including vitamin B6 and valproic acid for infantile spasms.